354 related articles for article (PubMed ID: 24720386)
1. RARA fusion genes in acute promyelocytic leukemia: a review.
De Braekeleer E; Douet-Guilbert N; De Braekeleer M
Expert Rev Hematol; 2014 Jun; 7(3):347-57. PubMed ID: 24720386
[TBL] [Abstract][Full Text] [Related]
2. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
Zhu G
Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507
[TBL] [Abstract][Full Text] [Related]
3. [RXR, a key member of the oncogenic complex in acute promyelocytic leukemia].
Halftermeyer J; Le Bras M; De Thé H
Med Sci (Paris); 2011 Nov; 27(11):973-8. PubMed ID: 22130024
[TBL] [Abstract][Full Text] [Related]
4. A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene.
Kikuma T; Nakamachi Y; Noguchi Y; Okazaki Y; Shimomura D; Yakushijin K; Yamamoto K; Matsuoka H; Minami H; Itoh T; Kawano S
Int J Hematol; 2015 Dec; 102(6):713-8. PubMed ID: 26342691
[TBL] [Abstract][Full Text] [Related]
5. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia.
Yamamoto Y; Tsuzuki S; Tsuzuki M; Handa K; Inaguma Y; Emi N
Blood; 2010 Nov; 116(20):4274-83. PubMed ID: 20807888
[TBL] [Abstract][Full Text] [Related]
6. Recurrent
Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
[TBL] [Abstract][Full Text] [Related]
7. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
[TBL] [Abstract][Full Text] [Related]
8. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
9. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation.
Kamashev D; Vitoux D; De Thé H
J Exp Med; 2004 Apr; 199(8):1163-74. PubMed ID: 15096541
[TBL] [Abstract][Full Text] [Related]
10. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies.
Ablain J; Leiva M; Peres L; Fonsart J; Anthony E; de Thé H
J Exp Med; 2013 Apr; 210(4):647-53. PubMed ID: 23509325
[TBL] [Abstract][Full Text] [Related]
12. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
[TBL] [Abstract][Full Text] [Related]
14. Acute Promyelocytic Leukemia: A Review and Discussion of Variant Translocations.
Adams J; Nassiri M
Arch Pathol Lab Med; 2015 Oct; 139(10):1308-13. PubMed ID: 26414475
[TBL] [Abstract][Full Text] [Related]
15. Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia.
Mozziconacci MJ; Liberatore C; Grignani F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
Leukemia; 1999 Jun; 13(6):862-8. PubMed ID: 10360373
[TBL] [Abstract][Full Text] [Related]
16. A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1).
Hirade K; Kusumoto S; Abe A; Noritake H; Ito A; Ri M; Komatsu H; Iida S; Yamamoto Y
Int J Hematol; 2022 Dec; 116(6):956-960. PubMed ID: 35854096
[TBL] [Abstract][Full Text] [Related]
17. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.
Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H
Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868
[TBL] [Abstract][Full Text] [Related]
18. Modified array-based comparative genomic hybridization detects cryptic and variant PML-RARA rearrangements in acute promyelocytic leukemia lacking classic translocations.
Gruver AM; Rogers HJ; Cook JR; Ballif BC; Schultz RA; Batanian JR; Fesler MJ; Tubbs RR
Diagn Mol Pathol; 2013 Mar; 22(1):10-21. PubMed ID: 23370423
[TBL] [Abstract][Full Text] [Related]
19. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
[TBL] [Abstract][Full Text] [Related]
20. The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.
Catalano A; Dawson MA; Somana K; Opat S; Schwarer A; Campbell LJ; Iland H
Blood; 2007 Dec; 110(12):4073-6. PubMed ID: 17712046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
